RDYNYSEPharmaceutical PreparationsFiscal year ends March 31

DR REDDYS LABORATORIES LTD

Financials through fiscal 2026, year ended Mar 31, 2026

$13.08+0.01 (+0.08%)

Close on Oct 19, 2026

Fundamental chart

Pick a measure to chart its full history

₹335.93BFY2026, +8.1% a year since FY2016

Parsed from the XBRL in Dr Reddys Laboratories's annual and quarterly filings with the SEC
Per-share figures adjusted for the 5-for-1 split on Jun 6, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is RDY.

Revenue growth3.2% · median 7.4%

Gross margin52.8% · median 67.9%

Operating margin15.0% · median 11.4%

Net margin12.8% · median 9.8%

Advertisement
300 × 250